CN Patent

CN108778281A — 一种吡啶酮类衍生物药物组合物及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2018-11-09 · 8y expired

What this patent protects

本发明提供了一种吡啶酮类衍生物药物组合物及其制备方法。具体而言，本发明提供了一种含有吡啶酮类衍生物或其可药用盐的药物组合物及其制备方法，所述的药物组合物包含活性成分2‑((2‑氟‑4‑碘苯基)氨基)‑1‑甲基‑4‑((6‑甲基吡啶‑3‑基)氧代)‑6‑羰基‑1,6‑二氢吡啶‑3‑甲酰胺或其可药用盐，和羟丙甲纤维素，该药物组合物具有良好的溶出度。

USPTO Abstract

本发明提供了一种吡啶酮类衍生物药物组合物及其制备方法。具体而言，本发明提供了一种含有吡啶酮类衍生物或其可药用盐的药物组合物及其制备方法，所述的药物组合物包含活性成分2‑((2‑氟‑4‑碘苯基)氨基)‑1‑甲基‑4‑((6‑甲基吡啶‑3‑基)氧代)‑6‑羰基‑1,6‑二氢吡啶‑3‑甲酰胺或其可药用盐，和羟丙甲纤维素，该药物组合物具有良好的溶出度。

Drugs covered by this patent

Patent Metadata

Patent number
CN108778281A
Jurisdiction
CN
Classification
—
Expires
2018-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.